Nebraska Microbiome Research Group Fall 2022 Symposium
Join us for the Nebraska Microbiome Research Group's Fall 2022 Symposium (in person and virtual)
“The Microbiome in Translational Medical Research”
Hosted by the Nebraska Microbiome Research Interest Group
November 9, 2022, 9 am to 12 pm
Pre-registration required at the link below by November 7. More information will be emailed to you after you register.
Register for the symposium here
In person attendance at UNMC, Michael F. Sorrell Center MSC 2010 is limited to 40 people and social distancing guidelines will be followed.
Symposium Information
9:15 AM Derrick Samuelson, Ph.D., “Gut-Lung Crosstalk in Alcohol-Associated Bacterial Pneumonia”
9:45 AM Chris D’Angelo, M.D., “Manipulating the Gut Microbiome to Improve Outcomes in Autologous Bone Marrow Transplantation for Multiple Myeloma and Lymphoma”
10:15 AM Peter Mannon, M.D., “The Gut Microbiome and Post-Solid Organ Transplant Metabolic Syndrome”
10:45 AM Coffee Break
11:15 AM Keynote speaker: Charles “Chuck” O. Elson, M.D., University of Alabama at Birmingham, “Swimming and Swarming Toward the Prevention of Crohn’s Disease”
Dr. Elson has been an active investigator in mucosal immunology and inflammatory bowel disease for the past 30 years and is responsible for the discovery of gut microbial flagellin as the immunodominant antigen driving experimental murine colitis and aberrant immune responses in Crohn’s disease. He is the Basil I. Hirschowitz Chair of Gastroenterology at UAB and Vice Chair of Research in the Department of Medicine. He was the founder and past president of the Society for Mucosal Immunology and an elected member of the Association of American Physicians, the National Academy of Inventors and a fellow of the American Academy of Microbiology.
Dr. Elson received his B.A. from the University of Notre Dame and his M.D. from Washington University in St. Louis. He trained in Internal Medicine at New York Hospital/Cornell, then did his Gastroenterology fellowship at the University of Chicago. After doing full-time research in immunology at N.I.H., he joined the Faculty of the Division of Gastroenterology at the Medical College of Virginia. He moved to the University of Alabama at Birmingham and served as Director of the Division of Gastroenterology and Hepatology from 1987-2001.
Dr. Elson’s contributions to science include but are not limited to the:
- Discovery of cholera toxin as a mucosal adjuvant
- Development of mouse models of colitis
- Regulation of the CD4 T cell response to microbiota
- Identification of flagellin as an immunodominant antigen in experimental colitis and in Chron’s disease